C. Zorrilla

718 total citations
15 papers, 536 citations indexed

About

C. Zorrilla is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, C. Zorrilla has authored 15 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 7 papers in Virology and 5 papers in Emergency Medicine. Recurrent topics in C. Zorrilla's work include HIV/AIDS Research and Interventions (10 papers), HIV Research and Treatment (7 papers) and HIV/AIDS drug development and treatment (6 papers). C. Zorrilla is often cited by papers focused on HIV/AIDS Research and Interventions (10 papers), HIV Research and Treatment (7 papers) and HIV/AIDS drug development and treatment (6 papers). C. Zorrilla collaborates with scholars based in Puerto Rico, United States and Belgium. C. Zorrilla's co-authors include Jason J. Pitt, Mary Glenn Fowler, Celine Hanson, Jack Moye, Ronald C. Hershow, Sheldon H. Landesman, Leslie A. Kalish, Hermann Mendez, Rachel Nugent and Carlos Javier Gómez Díaz and has published in prestigious journals such as Science, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

C. Zorrilla

15 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Zorrilla Puerto Rico 12 421 193 187 116 116 15 536
Jean Whitehouse United States 7 449 1.1× 228 1.2× 222 1.2× 49 0.4× 133 1.1× 7 546
Paola Germano Italy 14 522 1.2× 263 1.4× 198 1.1× 39 0.3× 150 1.3× 25 635
Beverly Bohannon United States 9 316 0.8× 76 0.4× 134 0.7× 79 0.7× 119 1.0× 18 401
Georgette Adjorlolo-Johnson United States 11 393 0.9× 229 1.2× 232 1.2× 57 0.5× 61 0.5× 14 518
Ricardo Hugo de Oliveira Brazil 11 245 0.6× 122 0.6× 82 0.4× 50 0.4× 101 0.9× 25 335
Jean Leidner Botswana 13 390 0.9× 98 0.5× 188 1.0× 131 1.1× 138 1.2× 30 590
Peckham Cs United Kingdom 7 344 0.8× 172 0.9× 220 1.2× 45 0.4× 74 0.6× 14 474
Mehri S. McKellar United States 16 461 1.1× 190 1.0× 308 1.6× 45 0.4× 100 0.9× 52 649
Thalita Fernandes de Abreu Brazil 11 261 0.6× 56 0.3× 127 0.7× 66 0.6× 86 0.7× 40 368
Varsha Chohan Kenya 7 237 0.6× 174 0.9× 98 0.5× 64 0.6× 26 0.2× 8 347

Countries citing papers authored by C. Zorrilla

Since Specialization
Citations

This map shows the geographic impact of C. Zorrilla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Zorrilla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Zorrilla more than expected).

Fields of papers citing papers by C. Zorrilla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Zorrilla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Zorrilla. The network helps show where C. Zorrilla may publish in the future.

Co-authorship network of co-authors of C. Zorrilla

This figure shows the co-authorship network connecting the top 25 collaborators of C. Zorrilla. A scholar is included among the top collaborators of C. Zorrilla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Zorrilla. C. Zorrilla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Lee, Michelle Sue Jann, C. Zorrilla, Yoshiki Omatsu, et al.. (2024). Acute malaria suppresses the B lymphocytic niche in the bone marrow through the alteration of CXCL12-abundant reticular cells. International Immunology. 36(7). 339–352. 2 indexed citations
2.
Osiyemi, Olayemi, et al.. (2019). Reduced exposure to darunavir and cobicistat in HIV‐1‐infected pregnant women receiving a darunavir/cobicistat‐based regimen. HIV Medicine. 20(5). 337–343. 19 indexed citations
3.
Shah, Seema, Jonathan Kimmelman, Anne Drapkin Lyerly, et al.. (2018). Bystander risk, social value, and ethics of human research. Science. 360(6385). 158–159. 32 indexed citations
4.
Ortíz, Ana P., et al.. (2017). Prevalence and correlates of cervical HPV infection in a clinic-based sample of HIV-positive Hispanic women. Papillomavirus Research. 4. 39–44. 11 indexed citations
5.
Kakuda, Thomas N., Barbara M. Ryan, C. Zorrilla, et al.. (2016). Pharmacokinetics of once‐daily darunavir/ritonavir in HIV‐1–infected pregnant women. HIV Medicine. 17(9). 643–652. 18 indexed citations
6.
Abdulhaqq, Shaheed, C. Zorrilla, Guolian Kang, et al.. (2015). HIV-1-negative female sex workers sustain high cervical IFNɛ, low immune activation, and low expression of HIV-1-required host genes. Mucosal Immunology. 9(4). 1027–1038. 21 indexed citations
7.
Zorrilla, C., Rodney Wright, Olayemi Osiyemi, et al.. (2012). Total and unbound darunavir (DRV) pharmacokinetics (PK) in HIV‐1‐infected pregnant women. Journal of the International AIDS Society. 15(S4). 1–2. 3 indexed citations
8.
Conradie, Francesca, C. Zorrilla, Olayemi Osiyemi, et al.. (2011). Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women. HIV Medicine. 12(9). 570–579. 50 indexed citations
9.
Mellins, Claude A., Kathleen Malee, Lynnette Harris, et al.. (2008). Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women. AIDS Care. 20(8). 958–968. 105 indexed citations
10.
Wojna, Valerie, Richard L. Skolasky, J. C. McArthur, et al.. (2007). Spanish Validation of the HIV Dementia Scale in Women. AIDS Patient Care and STDs. 21(12). 930–941. 23 indexed citations
11.
Pitt, Jason J., Kenneth McIntosh, Amy E. Colson, et al.. (2000). HIV-1 genotypic zidovudine drug resistance and the risk of maternal–infant transmission in the Women and Infants Transmission Study*. AIDS. 14(3). 263–271. 69 indexed citations
12.
García, Víctor, et al.. (1999). HIV infection of placental macrophages: effect on the secretion of HIV stimulatory cytokines.. PubMed. 45(4). 423–31. 13 indexed citations
13.
Burns, David, Ruth Tuomala, Ronald C. Hershow, et al.. (1997). Vaginal Colonization or Infection with Candida albicans in Human Immunodeficiency Virus-Infected Women During Pregnancy and During the Postpartum Period. Clinical Infectious Diseases. 24(2). 201–210. 40 indexed citations
14.
Cooper, Ellen, Rachel Nugent, Carlos Javier Gómez Díaz, et al.. (1996). After AIDS Clinical Trial 076: The Changing Pattern of Zidovudine Use during Pregnancy, and the Subsequent Reduction in the Vertical Transmission of Human Immunodeficiency Virus in a Cohort of Infected Women and Their Infants. The Journal of Infectious Diseases. 174(6). 1207–1211. 129 indexed citations
15.
Llano, Anuska, et al.. (1993). Multifunctional immunological monitoring of HIV positive patients: a novel staging system.. PubMed. 12(4). 277–81. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026